2nd Quarter - Report

SAM ACTION, INC. for SAM ACTION, INC.

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

The effects of marijuana on children, the nexus between marijuana and psychosis

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH)

Consumer Issues/Safety/Products CSP

safety issues surrounding marijuana

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: SENATE; White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ)

Government Issues GOV

federal role in marijuana laws, the legalization of marijuana, criminal justice reform

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: Food & Drug Administration (FDA); White House Office; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

the effects of marijuana on children, the nexus between marijuana and psychosis

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER US Rep. John Fleming (LA-4), Deputy Chief of Staff

Contacted: Justice, Dept of (DOJ); Natl Institutes of Health (NIH); SENATE; Office of Natl Drug Control Policy (NDCP); White House Office; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES

Law Enforcement/Crime/Criminal Justice LAW

H.R. 2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: SENATE; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP)

Bills named: S. 1028 (116th), H.R. 2093 (116th)

Medical/Disease Research/Clinical Labs MED

draft legislation of the MEDS Act to lower the barriers of researching marijuana

LobbyistCovered position, as disclosed
GARTH VAN METER Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); White House Office; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE

Banking BAN

H.R. 1595/S. 1200, SAFE Banking Act on marijuana banking and investment

LobbyistCovered position, as disclosed
FREDERICK BAIRD New —
JENNIFER BAIRD New —
JASON SCISM New Rep John Mica - Special Project Coord(6/98-10/98) and Leg Asst (10/98 - 11/98); House Commerce Comm - Staff Asst - 11/98-7/99;Clerk - 7/99 - 8/2000; Rep Darrell Issa Counsel 3/2005-5/2010 and Leg Dir, 4/08 -5/10; Oversight Comm, Counsel 08/08-12/08
GARTH VAN METER Deputy Chief of Staff, US Rep. John Fleming (LA-4)

Contacted: HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Drug Enforcement Administration (DEA)

Bills named: H.R. 1595 (116th), S. 1200 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.